Related Articles
Prognosis and outcome of patients with acute myeloid leukemia based on FLT3‑ITD mutation with or without additional abnormal cytogenetics
Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials
Role of glucose metabolism in the differential antileukemic effect of melatonin on wild‑type and FLT3‑ITD mutant cells
Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next‑generation sequencing
<em>In silico</em> and<em> in vitro</em> study of FLT3 inhibitors and their application in acute myeloid leukemia